NEWS

MEDIA

MEPSGEN Launches LNP Production Platform...Details Are Unveiled at BIO Conventional

MEPSGEN Launches LNP Production Platform...Details Are Unveiled at BIO Conventional

2023-06-02

MEPSGEN signs MOU with CELLARTGEN

MEPSGEN signs MOU with CELLARTGEN

2023-05-25

MEPSGEN signs MOU with CorestemChemon

MEPSGEN signs MOU with CorestemChemon

2023-05-19

MEPSGEN signs MOU with Woojung Bio

MEPSGEN signs MOU with Woojung Bio

2023-05-18

Come and say hello to MEPSGEN at the BIO KOREA 2023

Come and say hello to MEPSGEN at the BIO KOREA 2023

2023-05-09

MEPSGEN, developing new medicines using human organs-on-chips technology

MEPSGEN, developing new medicines using human organs-on-chips technology

2023-02-10

 YongTae Kim(CEO of MEPSGEN) is attending 'MPS and Beyond symposium'

YongTae Kim(CEO of MEPSGEN) is attending 'MPS and Beyond symposium'

2023-02-08

Online seminar : 'Microphysiological Barrier System for Drug Development'

Online seminar : 'Microphysiological Barrier System for Drug Development'

2023-02-06

2022 13th Korean Tissue Engineering and Regenerative Medicine Society.

2022 13th Korean Tissue Engineering and Regenerative Medicine Society.

2022-12-09

MEPSGEN is attending the 2022 Korean BioChip Society Fall Conference in Jeju, November 2-4.

MEPSGEN is attending the 2022 Korean BioChip Society Fall Conference in Jeju, November 2-4.

2022-11-02

[1st block of Bio] Sharing the interview of Robert Langer, MIT professor.

[1st block of Bio] Sharing the interview of Robert Langer, MIT professor.

2022-10-22

Organ-on-a-chip will surely play critical roles in predictive clinical trials, including faster time to drug discovery

Organ-on-a-chip will surely play critical roles in predictive clinical trials, including faster time to drug discovery

2022-10-20

MEPSGEN_2022 KAAT Conference: 3D MPS and Organoid meet together.

MEPSGEN_2022 KAAT Conference: 3D MPS and Organoid meet together.

2022-09-02

Hoon Suk Rho(CTO of MEPSGEN) presenting MEPSGEN at BIOPLUS INTERPHEX KOREA 2022, COEX.

Hoon Suk Rho(CTO of MEPSGEN) presenting MEPSGEN at BIOPLUS INTERPHEX KOREA 2022, COEX.

2022-08-02

MEPS-BBB was selected for Blood-brain barrier research model  at Goizueta Alzheimer’s Disease Research Center, Emory University.

MEPS-BBB was selected for Blood-brain barrier research model at Goizueta Alzheimer’s Disease Research Center, Emory University.

2022-07-15

MEPSGEN Adds $7.94 Million to Series B

MEPSGEN Adds $7.94 Million to Series B

2022-07-14

‘Organ-on-a-chip’, capable of replacing 500 million laboratory animals per year... venture investment, showed movements.

‘Organ-on-a-chip’, capable of replacing 500 million laboratory animals per year... venture investment, showed movements.

2022-07-13

MEPSGEN, “Spur the development of new drugs based on human organ on a chip”

MEPSGEN, “Spur the development of new drugs based on human organ on a chip”

2022-07-13

MEPSGEN-OSONG Medical Innovation Foundation, Discussed about mutual cooperation and confirmed foundation infrastructure.

MEPSGEN-OSONG Medical Innovation Foundation, Discussed about mutual cooperation and confirmed foundation infrastructure.

2022-07-06

MEPSGEN, Participating Asia's largest global startup fair "Nextrise, Seoul 2022"

MEPSGEN, Participating Asia's largest global startup fair "Nextrise, Seoul 2022"

2022-06-15

Sitemap닫기

PRODUCT
MEPS-X
ProMEPS™
MST-X
PIPELINE
MG-X_Nanomedicine
TECHNOLOGY
MICROPHYSIOLOGICAL SYSTEM (MPS)
NANOPARTICLE PRODUCTION
NANOMEDICINE
SERVICE
RESEARCH SERVICE
RESEARCH EQUIPMENT
ABOUT
OVERVIEW
VISION
HISTORY
LOCATIONS
PARTNERSHIP
CONTACT
NEWS
NOTICE
MEDIA
ARTICLE
CAREERS
CULTURE
HIRING
PROCESS
WE'RE HIRING!